Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0U4QZ
|
||||
| Former ID |
DIB012712
|
||||
| Drug Name |
EU-517
|
||||
| Synonyms |
Mcl-1 inhibitors (cancer), Eutropics; BH3 mimetics/Mcl-1 inhibitors (cancer), Eutropics
|
||||
| Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Investigative | [543733] | ||
| Company |
Harvard Medical School
|
||||
| Target and Pathway | |||||
| Target(s) | Induced myeloid leukemia cell differentiation protein Mcl-1 | Target Info | Inhibitor | [543733] | |
| KEGG Pathway | PI3K-Akt signaling pathway | ||||
| MicroRNAs in cancer | |||||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Apoptosis signaling pathway | ||||
| CCKR signaling map ST | |||||
| Pathway Interaction Database | E2F transcription factor network | ||||
| Direct p53 effectors | |||||
| IL6-mediated signaling events | |||||
| HIF-1-alpha transcription factor network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.